AMAG PHARMACEUTICALS INC. 4
4 · AMAG PHARMACEUTICALS INC. · Filed Jan 9, 2014
Insider Transaction Report
Form 4
White Christopher G
Chief Business Officer and SVP
Transactions
- Sale
Common Stock
2014-01-08$23.91/sh−2,000$47,820→ 26,834 total - Sale
Common Stock
2014-01-09$20.61/sh−1,700$35,037→ 25,134 total - Sale
Common Stock
2014-01-09$21.40/sh−100$2,140→ 25,034 total - Sale
Common Stock
2014-01-09$22.41/sh−200$4,482→ 24,834 total
Footnotes (4)
- [F1]The shares reported on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person.
- [F2]The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual sales prices per share range from $23.77 - $24.07. Upon request by the Securities and Exchange Commission, AMAG Pharmaceuticals, Inc., or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price.
- [F3]The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual sales prices per share range from $20.12 - $21.00. Upon request by the Securities and Exchange Commission, AMAG Pharmaceuticals, Inc., or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price.
- [F4]The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual sales prices per share range from $22.40 - $22.41. Upon request by the Securities and Exchange Commission, AMAG Pharmaceuticals, Inc., or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price.